The clinical performance is complex and often involves multi-system congestion. Early identification and standardized clinical care are essential for improving prognosis. The diagnosis of the disease requires a combination of clinical performance, imaging, laboratory testing and pathological activation.
The platform can assist in matching the needs of a team of authoritative experts at home and abroad to provide accurate diagnosis and treatment programs. Treatment and management of PML-related treatment programs are individualized, usually including drug therapy, rehabilitation interventions, and regular follow-up to multidimensional management. In recent years, with the development of therapeutic, immune-regulatory therapy and precision medicine, many neurological diseases that have been difficult to treat have been significantly improved.
Treatment requires close monitoring of therapeutic effects and adverse reactions and timely adjustment according to changes in the disease. Multidisciplinary collaboration (MDT) is particularly important for the integrated management of brain whiteness associated with PML. 2.
Visiting China: arranging face-to-face treatment with authoritative experts, developing individualized treatment plans; 3. Full-service: providing one-stop services such as medical translation, medical care, accommodation arrangements; 4. Long-term follow-up: establishing a chronic disease management archive, continuous monitoring of disease changes and treatment effects.